Comparative temporal and dose-dependent morphological and transcriptional uterine effects elicited by tamoxifen and ethynylestradiol in immature, ovariectomized mice

BMC Genomics

Volumn 8, Issue , 2007, Pages

  Fong, Cora J ^a,b   Burgoon, Lyle D ^a,b   Williams, Kurt J ^b   Forgacs, Agnes L ^a,b   Zacharewski, Timothy R ^a,b  

^a Michigan State University   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 1A; CYCLINE; DNA; ESTROGEN RECEPTOR; ETHINYLESTRADIOL; LIPID; NUCLEOTIDE; PROTEIN; PROTEIN FOS; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; DNA REPLICATION; DOSE TIME EFFECT RELATION; DRUG RESPONSE; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION PROFILING; GLYCOLYSIS; HISTOPATHOLOGY; IMMUNE RESPONSE; LIPID METABOLISM; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEOTIDE METABOLISM; OVARIECTOMY; PROTEIN METABOLISM; PROTEIN SYNTHESIS; SINGLE DRUG DOSE; UTERUS; UTERUS GROWTH; UTERUS WEIGHT; WATER TRANSPORT; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; GENETIC TRANSCRIPTION; METABOLISM; ORGAN SIZE;

MUS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHINYL ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; OVARIECTOMY; TAMOXIFEN; TRANSCRIPTION, GENETIC; UTERUS;

EID: 34447518715     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-8-151     Document Type: Article

References (83)

1. Mandlekar S Hebbar V Christov K Kong AN Pharmacodynamics of tamoxifen and its 4-hydroxy and N-desmethyl metabolites: Activation of caspases and induction of apoptosis in rat mammary tumors and in human breast cancer cell lines Cancer Res 2000 60 6601-6606 11118041
2. Jordan VC Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer Br J Pharmacol 1993 110 507-517 8242225
3. Wijayaratne AL Nagel SC Paige LA Christensen DJ Norris JD Fowlkes DM McDonnell DP Comparative analyses of mechanistic differences among antiestrogens Endocrinology 1999 140 5828-5840 10579349
4. Johnson MD Zuo H Lee KH Trebley JP Rae JM Weatherman RV Desta Z Flockhart DA Skaar TC Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen Breast Cancer Res Treat 2004 85 151-159 15111773
5. Fisher DE Apoptosis in cancer therapy: Crossing the threshold Cell 1994 78 539-542 8069905
6. Carthew P Edwards RE Nolan BM Tucker MJ Smith LL Compartmentalized uterotrophic effects of tamoxifen, toremifene, and estradiol in the ovariectomized Wistar (Han) rat Toxicol Sci 1999 48 197-205 10353311
7. Kohlerova E Skarda J Mouse bioassay to assess oestrogenic and anti-oestrogenic compounds: Hydroxytamoxifen, diethylstilbestrol and genistein J Vet Med A Physiol Pathol Clin Med 2004 51 209-217 15315699
8. Osborne CK Zhao H Fuqua SA Selective estrogen receptor modulators: structure, function, and clinical use J Clin Oncol 2000 18 3172-3186 10963646
9. Lewis JS Jordan VC Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance Mutat Res 2005 591 247-263 16083919
10. Smith CL Nawaz Z O'Malley BW Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen Mol Endocrinol 1997 11 657-666 9171229
11. Vogel VG Costantino JP Wickerham DL Cronin WM Cecchini RS Atkins JN Bevers TB Fehrenbacher L Pajon ER Jr. Wade JL 3rd Robidoux A Margolese RG James J Lippman SM Runowicz CD Ganz PA Reis SE McCaskill-Stevens W Ford LG Jordan VC Wolmark N Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial Jama 2006 295 2727-2741 16754727
12. Reel JR Lamb IJ Neal BH Survey and assessment of mammalian estrogen biological assays for hazard characterization Fundam Appl Toxicol 1996 34 288-305 8954758
13. Jordan VC Collins MM Rowsby L Prestwich G A monohydroxylated metabolite of tamoxifen with potent antioestrogenic activity J Endocrinol 1977 75 305-316 591813
14. Boverhof DR Fertuck KC Burgoon LD Eckel JE Gennings C Zacharewski TR Temporal- and dose-dependent hepatic gene expression changes in immature ovariectomized mice following exposure to ethynyl estradiol Carcinogenesis 2004 25 1277-1291 14976129
15. Fertuck KC Eckel JE Gennings C Zacharewski TR Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol Physiol Genomics 2003 15 127-141 12915738
16. Kwekel JC Burgoon LD Burt JW Harkema JR Zacharewski TR A cross-species analysis of the rodent uterotrophic program: Elucidation of conserved responses and targets of estrogen signaling Physiol Genomics 2005 23 327-342 16174780
17. Van den Belt K Berckmans P Vangenechten C Verheyen R Witters H Comparative study on the in vitro/in vivo estrogenic potencies of 17beta-estradiol, estrone, 17alpha-ethynylestradiol and nonylphenol Aquat Toxicol 2004 66 183-195 15036873
18. Carthew P Edwards RE Nolan BM Uterotrophic effects of tamoxifen, toremifene, and raloxifene do not predict endometrial cell proliferation in the ovariectomized CD1 mouse Toxicol Appl Pharmacol 1999 158 24-32 10387929
19. Jordan VC Dix CJ Naylor KE Prestwich G Rowsby L Nonsteroidal antiestrogens: Their biological effects and potential mechanisms of action J Toxicol Environ Health 1978 4 363-390 207880
20. Jordan VC Dix CJ Effect of oestradiol benzoate, tamoxifen and monohydroxytamoxifen on immature rat uterine progesterone receptor synthesis and endometrial cell division J Steroid Biochem 1979 11 285-291 491598
21. Loeb L Suntzeff V Burns EL Growth processes induced by estrogenic hormones in the uterus of the mouse Am J Cancer 1938 34 413-427 12338106
22. Moggs JG Tinwell H Spurway T Chang HS Pate I Lim FL Moore DJ Soames A Stuckey R Currie R Zhu T Kimber I Ashby J Orphanides G Phenotypic anchoring of gene expression changes during estrogen-induced uterine growth Environ Health Perspect 2004 112 1589-1606 1247656 15598610
23. Yuen T Wurmbach E Pfeffer RL Ebersole BJ Sealfon SC Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays Nucleic Acids Res 2002 30 e48 115302 12000853
24. Bourdeau V Deschenes J Metivier R Nagai Y Nguyen D Bretschneider N Gannon F White JH Mader S Genome-wide identification of high-affinity estrogen response elements in human and mouse Mol Endocrinol 2004 18 1411-1427 15001666
25. Black LJ Goode RL Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice Life Sci 1980 26 1453-1458 7382727
26. Fromson JM Pearson S Bramah S The metabolism of tamoxifen (I.C.I. 46,474). I. In laboratory animals Xenobiotica 1973 3 693-709 4361333
27. Fromson JM Pearson S Bramah S The metabolism of tamoxifen (I.C.I. 46,474). II. In female patients Xenobiotica 1973 3 711-714 4783632
28. Robinson SP Langan-Fahey SM Johnson DA Jordan VC Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient Drug Metab Dispos 1991 19 36-43 1673419
29. Kiriwat O Fotherby K Pharmacokinetics of oral contraceptive steroids after morning or evening administration Contraception 1983 27 153-160 6851554
30. Gray CA Bartol FF Tarleton BJ Wiley AA Johnson GA Bazer FW Spencer TE Developmental biology of uterine glands Biol Reprod 2001 65 1311-1323 11673245
31. Sanyal A Riggs BL Spelsberg TC Khosla S Bone marrow stromal cells express two distinct splice variants of ER-alpha that are regulated by estrogen J Cell Biochem 2005 94 88-97 15517596
32. Boverhof DR Burgoon LD Tashiro C Chittim B Harkema JR Jump DB Zacharewski TR Temporal and dose-dependent hepatic gene expression patterns in mice provide new insights into TCDD-Mediated hepatotoxicity Toxicol Sci 2005 85 1048-1063 15800033
33. Naciff JM Overmann GJ Torontali SM Carr GJ Tiesman JP Richardson BD Daston GP Gene expression profile induced by 17 alpha-ethynyl estradiol in the prepubertal female reproductive system of the rat Toxicol Sci 2003 72 314-330 12655037
34. Yamashita S Takayanagi A Shimizu N Temporal and cell-type specific expression of c-fos and c-jun protooncogenes in the mouse uterus after estrogen stimulation Endocrinology 1996 137 5468-5475 8940373
35. Fan TJ Han LH Cong RS Liang J Caspase family proteases and apoptosis Acta Biochim Biophys Sin (Shanghai) 2005 37 719-727 16270150
36. Lai MD Jiang MJ Wing LY Estrogen stimulates expression of p21Waf1/Cip1 in mouse uterine luminal epithelium Endocrine 2002 17 233-239 12108525
37. Kirkland JL Murthy L Stancel GM Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus Mol Pharmacol 1993 43 709-714 8502228
38. Mylonas I Jeschke U Wiest I Hoeing A Vogl J Shabani N Kuhn C Schulze S Kupka MS Friese K Inhibin/activin subunits alpha, beta-A and beta-B are differentially expressed in normal human endometrium throughout the menstrual cycle Histochem Cell Biol 2004 122 461-471 15480736
39. Nakayama H Sano T Motegi A Oyama T Nakajima T Increasing 14-3-3 sigma expression with declining estrogen receptor alpha and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma Pathol Int 2005 55 707-715 16271083
40. Krebs J Saremaslani P Caduff R ALG-2: A Ca2+ -binding modulator protein involved in cell proliferation and in cell death Biochim Biophys Acta 2002 1600 68-73 12445461
41. Fernandez-Zapico ME Gonzalez-Paz NC Weiss E Savoy DN Molina JR Fonseca R Smyrk TC Chari ST Urrutia R Billadeau DD Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis Cancer Cell 2005 7 39-49 15652748
42. Mehus JG Deloukas P Lambeth DO NME6: A new member of the nm23/nucleoside diphosphate kinase gene family located on human chromosome 3p21.3 Hum Genet 1999 104 454-459 10453732
43. Rampazzo C Kost-Alimova M Ruzzenente B Dumanski JP Bianchi V Mouse cytosolic and mitochondrial deoxyribonucleotidases: CDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs Gene 2002 294 109-117 12234672
44. Jablonski EM McConnell NA Hughes FM Jr. Huet-Hudson YM Estrogen regulation of aquaporins in the mouse uterus: Potential roles in uterine water movement Biol Reprod 2003 69 1481-1487 12855592
45. Koyama N Ishibashi K Kuwahara M Inase N Ichioka M Sasaki S Marumo F Cloning and functional expression of human aquaporin8 cDNA and analysis of its gene Genomics 1998 54 169-172 9806845
46. McMahon RJ Cousins RJ Mammalian zinc transporters J Nutr 1998 128 667-670 9521625
47. Suzuki T Ishihara K Migaki H Matsuura W Kohda A Okumura K Nagao M Yamaguchi-Iwai Y Kambe T Zinc transporters, ZnT5 and ZnT7, are required for the activation of alkaline phosphatases, zinc-requiring enzymes that are glycosylphosphatidylinositol-anchored to the cytoplasmic membrane J Biol Chem 2005 280 637-643 15525635
48. Lee JY Kim JH Hong SH Cherny RA Bush AI Palmiter RD Koh JY Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain J Biol Chem 2004 279 8602-8607 14681234
49. Burckhardt BC Burckhardt G Transport of organic anions across the basolateral membrane of proximal tubule cells Rev Physiol Biochem Pharmacol 2003 146 95-158 12605306
50. Ljubojevic M Balen D Breljak D Kusan M Anzai N Bahn A Burckhardt G Sabolic I Renal expression of organic anion transporter OAT2 in rats and mice is regulated by sex hormones Am J Physiol Renal Physiol 2006
51. Inoue A Yoshida N Omoto Y Oguchi S Yamori T Kiyama R Hayashi S Development of cDNA microarray for expression profiling of estrogen-responsive genes J Mol Endocrinol 2002 29 175-192 12370120
52. del Carmen Garcia Molina Wolgien M da Silva ID Villanova FE Yumi Otsuka A Borra RC Lima Reis LF Carvalho AF Baracat EC Gebrim LH Differential gene expression assessed by cDNA microarray analysis in breast cancer tissue under tamoxifen treatment Eur J Gynaecol Oncol 2005 26 501-504 16285565
53. Scafoglio C Ambrosino C Cicatiello L Altucci L Ardovino M Bontempo P Medici N Molinari AM Nebbioso A Facchiano A Calogero RA Elkon R Menini N Ponzone R Biglia N Sismondi P Bortoli MD Weisz A Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells J Cell Biochem 2006 16514628
54. Gadal F Starzec A Bozic C Pillot-Brochet C Malinge S Ozanne V Vicenzi J Buffat L Perret G Iris F Crepin M Integrative analysis of gene expression patterns predicts specific modulations of defined cell functions by estrogen and tamoxifen in MCF7 breast cancer cells J Mol Endocrinol 2005 34 61-75 15691878
55. Frasor J Stossi F Danes JM Komm B Lyttle CR Katzenellenbogen BS Selective estrogen receptor modulators: Discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells Cancer Res 2004 64 1522-1533 14973112
56. Frasor J Chang EC Komm B Lin CY Vega VB Liu ET Miller LD Smeds J Bergh J Katzenellenbogen BS Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome Cancer Res 2006 66 7334-7340 16849584
57. Hodges LC Cook JD Lobenhofer EK Li L Bennett L Bushel PR Aldaz CM Afshari CA Walker CL Tamoxifen functions as a molecular agonist inducing cell cycle-associated genes in breast cancer cells Mol Cancer Res 2003 1 300-311 12612058
58. Green AR Styles JA Parrott EL Gray D Edwards RE Smith AG Gant TW Greaves P Al-Azzawi F White IN Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer Exp Toxicol Pathol 2005 56 255-263 15816354
59. Robertson DW Katzenellenbogen JA Hayes JR Katzenellenbogen BS Antiestrogen basicity--activity relationships: A comparison of the estrogen receptor binding and antiuterotrophic potencies of several analogues of (Z)-1,2-diphenyl-1-[4-[2-(dimethylamino)ethoxy]phenyl]-1-butene (tamoxifen, Nolvadex) having altered basicity J Med Chem 1982 25 167-171 7057423
60. Dowsett M Haynes BP Hormonal effects of aromatase inhibitors: Focus on premenopausal effects and interaction with tamoxifen J Steroid Biochem Mol Biol 2003 86 255-263 14623519
61. Giambiagi N Pasqualini JR Immunological differences between the estradiol-, tamoxifen- and 4-hydroxy-tamoxifen-estrogen receptor complexes detected by two monoclonal antibodies J Steroid Biochem 1988 30 213-217 3386244
62. Webb P Nguyen P Kushner PJ Differential SERM effects on corepressor binding dictate ERalpha activity in vivo J Biol Chem 2003 278 6912-6920 12482846
63. McDonnell DP Chang CY Norris JD Development of peptide antagonists that target estrogen receptor-cofactor interactions J Steroid Biochem Mol Biol 2000 74 327-335 11162941
64. Geum D Sun W Paik SK Lee CC Kim K Estrogen-induced cyclin D1 and D3 gene expressions during mouse uterine cell proliferation in vivo: differential induction mechanism of cyclin D1 and D3 Mol Reprod Dev 1997 46 450-458 9094091
65. Shiau AK Barstad D Loria PM Cheng L Kushner PJ Agard DA Greene GL The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen Cell 1998 95 927-937 9875847
66. Das D Peterson RC Scovell WM High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity Mol Endocrinol 2004 18 2616-2632 15256536
67. Kazmin D Prytkova T Cook CE Wolfinger R Chu TM Beratan D Norris JD Chang CY McDonnell DP Linking ligand-induced alterations in androgen receptor structure to differential gene expression: A first step in the rational design of selective androgen receptor modulators Mol Endocrinol 2006 20 1201-1217 16574741
68. Meijer OC Kalkhoven E van der Laan S Steenbergen PJ Houtman SH Dijkmans TF Pearce D de Kloet ER Steroid receptor coactivator-1 splice variants differentially affect corticosteroid receptor signaling Endocrinology 2005 146 1438-1448 15564339
69. Lim CK Yuan ZX Lamb JH White IN De Matteis F Smith LL A comparative study of tamoxifen metabolism in female rat, mouse and human liver microsomes Carcinogenesis 1994 15 589-593 8149466
70. White IN Tamoxifen: Is it safe? Comparison of activation and detoxication mechanisms in rodents and in humans Curr Drug Metab 2003 4 223-239 12769667
71. Goetz MP Knox SK Suman VJ Rae JM Safgren SL Ames MM Visscher DW Reynolds C Couch FJ Lingle WL Weinshilboum RM Fritcher EG Nibbe AM Desta Z Nguyen A Flockhart DA Perez EA Ingle JN The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen Breast Cancer Res Treat 2007 101 113-121 17115111
72. Deligdisch L Kalir T Cohen CJ de Latour M Le Bouedec G Penault-Llorca F Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer Gynecol Oncol 2000 78 181-186 10926800
73. Mourits MJ De Vries EG Willemse PH Ten Hoor KA Hollema H Van der Zee AG Tamoxifen treatment and gynecologic side effects: A review Obstet Gynecol 2001 97 855-866 11336777
74. Human Pathology Michigan State University http://www.humanpathology.msu.edu/histology
75. Research Technology Support Facility http://www.genomics.msu.edu
76. Rockett JC Dix DJ Application of DNA arrays to toxicology Environ Health Perspect 1999 107 681-685 1566480 10417368
77. dbZACH Home Page: Zacharewski Laboratory http://dbzach.fst.msu.edu/
78. Burgoon LD Eckel-Passow JE Gennings C Boverhof DR Burt JW Fong CJ Zacharewski T Protocols for the Assurance of Microarray Data Quality and Process Control Nucleic Acids Research 2005 33 e172 1278948 16272462
79. Eckel JE Gennings C Therneau TM Burgoon LD Boverhof DR Zacharewski TR Normalization of two-channel microarray experiments: A semiparametric approach Bioinformatics 2005 21 1078-1083 15513988
80. Eckel JE Gennings C Chinchilli VM Burgoon LD Zacharewski TR Empirical bayes gene screening tool for time-course or dose-response microarray data J Biopharm Stat 2004 14 647-670 15468757
81. Brazma A Hingamp P Quackenbush J Sherlock G Spellman P Stoeckert C Aach J Ansorge W Ball CA Causton HC Gaasterland T Glenisson P Holstege FC Kim IF Markowitz V Matese JC Parkinson H Robinson A Sarkans U Schulze-Kremer S Stewart J Taylor R Vilo J Vingron M Minimum information about a microarray experiment (MIAME)-toward standards for microarray data Nat Genet 2001 29 365-371 11726920
82. Burgoon LD Boutros PC Dere E Zacharewski TR dbZach: A MIAME-Compliant Toxicogenomic Supportive Relational Database Toxicol Sci 2005
83. Primer3 Input (primer3/input.htm version 0.3.0 modified for WI) http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi